Selectis Health (NASDAQ: GBCS) director reports insider share buy
Rhea-AI Filing Summary
Selectis Health, Inc. director and 10% owner Lance Baller filed a Form 4 reporting an indirect purchase of common stock. On December 18, 2025, an entity named High Speed Aggregate, Inc. acquired 6,192 shares of Selectis Health common stock at $2.20 per share, reported as an indirect beneficial holding for Baller.
After this transaction, Baller is listed as beneficially owning 161,965 shares of common stock directly. Indirectly, he is shown with 52,808 shares of common stock through High Speed Aggregate, Inc., 72,934 shares of common stock and 55,000 warrants through Ultimate Investments Corp., Inc., and 6,667 shares of common stock through Baller Family Foundation, Inc.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did GBCS (Selectis Health, Inc.) report on this Form 4?
The Form 4 shows that an entity named High Speed Aggregate, Inc. acquired 6,192 shares of Selectis Health, Inc. common stock on December 18, 2025 at a price of $2.20 per share, reported as an indirect beneficial holding for director and 10% owner Lance Baller.
Who is the reporting person on this GBCS Form 4 and what is their role?
The reporting person is Lance Baller, who is identified as both a Director and a 10% Owner of Selectis Health, Inc. (GBCS).
How many GBCS shares does Lance Baller beneficially own directly after the reported transaction?
Following the reported transaction, Lance Baller is shown as beneficially owning 161,965 shares of Selectis Health, Inc. common stock directly.
What indirect GBCS share holdings are associated with Lance Baller on this Form 4?
The Form 4 lists indirect beneficial ownership for Lance Baller of 52,808 shares of common stock through High Speed Aggregate, Inc., 72,934 shares of common stock through Ultimate Investments Corp., Inc., and 6,667 shares of common stock through Baller Family Foundation, Inc.
What warrant holdings related to GBCS does Lance Baller report indirectly?
The filing shows 55,000 warrants to purchase Selectis Health, Inc. common stock at an exercise price of $2.25, exercisable from July 1, 2023 until December 31, 2027, held indirectly through Ultimate Investments Corp., Inc.
Was the reported GBCS transaction on this Form 4 a purchase or sale of common stock?
The reported transaction for 6,192 shares of Selectis Health, Inc. common stock on December 18, 2025 is coded as P, indicating a purchase at $2.20 per share through High Speed Aggregate, Inc..